Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Super-Affinity Antibody

Anti-Vaccinia L1R/Protein L1 Antibody (7D11)

Catalog #:   RVV13903 Specific References (11) DATASHEET
Host species: Human
Isotype: IgG1, kappa
Applications: ELISA, Neutralization
Expression system: Mammalian Cells
Overview

Catalog No.

RVV13903

Expression system

Mammalian Cells

Species reactivity

Vaccinia

Host species

Human

Isotype

IgG1, kappa

Clonality

Monoclonal

Target

Protein L1, Virion membrane protein M25, VACWR088, L1R

Concentration

1.79 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P07612

Applications

ELISA, Neutralization

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

7D11

Data Image
References

Enhanced Expression of the L1R Gene of Vaccinia Virus by the tPA Signal Sequence Inserted in a Fowlpox-Based Recombinant Vaccine., PMID:39460282

L1R, A27L, A33R and B5R vaccinia virus genes expressed by fowlpox recombinants as putative novel orthopoxvirus vaccines., PMID:23578094

Engineering the vaccinia virus L1 protein for increased neutralizing antibody response after DNA immunization., PMID:19257896

Vaccinia virus L1 binds to cell surfaces and blocks virus entry independently of glycosaminoglycans., PMID:19162289

Disparity between levels of in vitro neutralization of vaccinia virus by antibody to the A27 protein and protection of mice against intranasal challenge., PMID:18524827

Targeting the vaccinia virus L1 protein to the cell surface enhances production of neutralizing antibodies., PMID:18485547

Redundancy and plasticity of neutralizing antibody responses are cornerstone attributes of the human immune response to the smallpox vaccine., PMID:18234801

Structural basis for the binding of the neutralizing antibody, 7D11, to the poxvirus L1 protein., PMID:17688903

Resistance of a vaccinia virus A34R deletion mutant to spontaneous rupture of the outer membrane of progeny virions on the surface of infected cells., PMID:17553539

Human T-cell responses to vaccinia virus envelope proteins., PMID:17005679

Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions., PMID:15367588

Datasheet
$ 372
Product specifications
100 μg 372 1 mg 1860

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Vaccinia L1R/Protein L1 Antibody (7D11) [RVV13903]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only